Phase 2b Study of ALTO-100 in MDD

Clinical trial NCT05712187 · COMPLETED

Trial details

NCT number: NCT05712187
Sponsor: Alto Neuroscience
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2023-01-10
Primary completion: 2024-09-05
Enrollment: 301

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.